Tag: Prescription Drugs
Intensive BP Reduction Effective for Lowering All-Cause Dementia Risk
Findings seen among 33,995 individuals aged 40 years and older with untreated hypertension
Hydroxyurea Has Sustained Clinical Benefits in Children With Sickle Cell Anemia
Fewer ED visits per year and fewer hospital days per year seen in association with hydroxyurea use
Early Combination of Lipid-Lowering Therapy Beneficial After Myocardial Infarction
In a recent study, one-year MACE incidences were 1.79, 2.58, and 4.03 per 100 patient-years for early, late, and no ezetimibe added to statins
Efanesoctocog Alfa Not Cost-Effective for Prophylaxis in Hemophilia A
Efanesoctocog alfa needs to be priced at <53 and <59 percent of current price for conventional and distributional cost-effectiveness
Common Medications Tied to Older Age at Onset of Parkinson Disease
Almost 10-year delay seen for patients who were started on adrenergic blockers before onset of PD symptoms
School-Based Asthma Therapy Boosts Asthma Control, Cuts Acute Health Care Use
Program also helps close health disparities gap for Black and Latino children at high risk for poor asthma outcomes
Brensocatib Leads to Lower Rate of Pulmonary Exacerbations in Bronchiectasis
Annualized rate of pulmonary exacerbations lower in 10-mg and 25-mg brensocatib groups versus placebo
Single-Dose Baloxavir Treatment Can Reduce Influenza Transmission
Transmission of laboratory-confirmed influenza significantly lower with baloxavir versus placebo by day 5
Most Patients Newly Diagnosed With A-Fib Do Not Receive Anticoagulants
One-year stroke risk was 0.7 and 1.8 percent for patients with CHA2DS2-VA scores of 1 to 4 and 5 to 8
FDA Approves Dupixent for Chronic Spontaneous Urticaria
Approval granted for adults and children 12 years and older who remain symptomatic despite antihistamine treatment
